Prior Pneumonitis as a Risk Factor for Treatment-Associated Pneumonitis With Immune Checkpoint Inhibitor Therapy

Single-Agent Pembrolizumab Active Against STK11- and KEAP1- Mutated NSCLC According to KEYNOTE-042 Analysis

Impact of COVID-19 on the Diagnostic Workup of Lung Cancer

Systemic Therapy for Advanced Stage Lung Cancer During the COVID-19 Pandemic

Impact of COVID-19 on Treatment of Lung Cancer Patients with Local or Locoregional Disease

Practical Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

#LCSM Chat Topic 6/4/2020: #ASCO20 Roundup for #LungCancer

IASLC 2020 World Conference on Lung Cancer Postponed

First-Ever IASLC School of Nursing Held at Latin American Lung Cancer Regional Meeting in Mexico City

Highlights From the 2019 IASLC Latin American Conference in Lung Cancer

IASLC 2019 World Conference on Lung Cancer: Collaborative Formats, Novel Data

IASLC’s Inaugural Mesothelioma Meeting Sets Baseline for Strategic Approach to Patient Care